Summary: Barclays Capital Inc. Series 2011-14B And 2011-15B; Residual Certificates; Tender Option Certificates/Bonds Mar 11

  • ID: 2087570
  • March 2011
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services assigned its 'AAA/A-1+' and 'AAA' ratings to Barclays Capital Inc.'s floating rate trust receipts and residual interest trust receipts, respectively, series 2011-14B and 2011-15B, relating to New York State Dormitory Authority's personal income tax revenue bonds (education) series 2005. The long-term component of the rating is based on the underlying bonds. The short-term component of the rating is based on Barclays Bank PLC until March 1, 2012. USPF Criteria: Secondary Market Derivative Products, June 27, 2007...

Companies mentioned in this report are: New York State,Barclays Capital Inc.
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

This product consists of a Summary Analysis: Bi-annual (at least). An abbreviated analysis containing Standard & Poor's issuer credit ratings as of the time the article was published. The analysis includes a rating rationale - the basis on which the rating was assigned - and an outlook section if the issuer is not on CreditWatch. Financial statistics are not included.

Note: Product cover images may vary from those shown
2 of 3

New York State,Barclays Capital Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.